PMcardio receives FDA Breakthrough Device Designation — read the full story

PM Magazine

Powerful Medical Receives FDA Breakthrough Device Designation for PMcardio STEMI AI ECG Model

Powerful Medical, a leader in AI-driven cardiovascular diagnostics, announces that its PMcardio STEMI AI ECG model has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). This designation recognizes PMcardio as a breakthrough technology for the detection of ST-elevation myocardial infarction (STEMI) and STEMI equivalents—a life-threatening cardiac condition requiring immediate intervention.

Editor's Choice

Collage showing a conference speaker, PMcardio app UI, hospital partnerships across Europe, and a research award ceremony.

May Highlights from Powerful Medical: PMcardio 3.0 Launch, STEMI Research, and Clinical Breakthroughs

Introducing PMcardio for Individuals 3.0: A New Era in AI-Powered Second Opinions for ECG Interpretation

Introducing PMcardio for Individuals 3.0: A New Era in AI-Powered Second Opinions for ECG Interpretation

Winners+of+AHA's+Health+Tech+Competition+2024

Powerful Medical Wins Best Science Pitch and Overall Winner at AHA Health Tech Competition 2024

Image is showing logos of the two companies mentioned in the text - PMcardio and Alphaiota

Alphaiota Expands Strategic Partnership with PMcardio to Launch First AI-Powered Heart Attack Diagnostic Platform in Saudi Arabia

Alphaiota and PMcardio announce the expansion of their strategic partnership to bring the first AI-powered heart attack diagnostic solution to the Kingdom of Saudi Arabia. Developed by Powerful Medical, a medical device manufacturer specializing in AI-driven cardiovascular diagnostics, PMcardio will be introduced by Alphaiota as the exclusive distributor in the region, marking a first-of-its-kind deployment in the Middle East.
Image ilustrating the VAIA grant reception containing logos of important public institutions

Powerful Medical Awarded €1M EU-Funded Grant by Slovak Ministry of Economy to Advance AI-ECG Heart Attack Diagnostics

Powerful Medical has received over €985,000 in funding from the Slovak Ministry of Economy, as part of the EU-funded Recovery and Resilience Plan. The grant supports the continued development of our AI-based ECG interpretation technology, focused on improving early diagnosis and treatment of acute coronary syndromes (ACS).
Collage showing a conference speaker, PMcardio app UI, hospital partnerships across Europe, and a research award ceremony.

May Highlights from Powerful Medical: PMcardio 3.0 Launch, STEMI Research, and Clinical Breakthroughs

May was a milestone month at Powerful Medical. From launching PMcardio for Individuals 3.0 and showcasing new explainable AI tools, to advancing STEMI detection through international research and clinical collaboration—discover the breakthroughs that are shaping the future of cardiac care.
Introducing PMcardio for Individuals 3.0: A New Era in AI-Powered Second Opinions for ECG Interpretation

Introducing PMcardio for Individuals 3.0: A New Era in AI-Powered Second Opinions for ECG Interpretation

PMcardio has long been a trusted diagnostic companion to over 100,000 providers worldwide—from emergency departments and clinics to rural ambulances and primary care offices. With the launch of PMcardio for Individuals 3.0, we’re raising the bar once again—delivering instant, explainable AI support for ECG interpretation, empowering faster, more confident decisions in acute cardiovascular care settings.

Stay on the pulse with our newsletter

Your submission was successful